Association between serum interleukin-6 concentrations and mortality in older adults: The rancho bernardo study

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Lee, Jeffrey K ^a   Bettencourt, Ricki ^b   Brenner, David ^a,b   Le, Thuy Anh ^a,b   Barrett Connor, Elizabeth ^b   Loomba, Rohit ^a,b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; INTERLEUKIN 6; TRIACYLGLYCEROL;

ADULT; AGE; AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; DIABETES MELLITUS; FEMALE; FOLLOW UP; GENDER; HUMAN; HYPERTENSION; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MORTALITY; PREVALENCE; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; SMOKING; BLOOD; MIDDLE AGED; NEOPLASM;

AGED; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; INTERLEUKIN-6; LIVER DISEASES; MALE; MIDDLE AGED; NEOPLASMS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES;

EID: 84859735371     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0034218     Document Type: Article

References (36)

1. Papanicolaou DA, Wilder RL, Manolagas SC, Chrousos GP, (1998) The pathophysiologic roles of interleukin-6 in human disease. Ann Intern Med; 128 (2): 127-137.
2. Kovalovich K, Li W, DeAngelis R, Greenbaum LE, Ciliberto G, et al. (2001) Interleukin-6 protects against Fas-mediated death by establishing a critical level of anti-apoptotic hepatic proteins FLIP, Bcl-2, and Bcl-xL. J Biol Chem; 276 (28): 26605-26613.
3. Jin X, Zimmers TA, Perez EA, Pierce RH, Zhang Z, et al. (2006) Paradoxical effects of short- and long-term interleukin-6 exposure on liver injury and repair. Hepatology; 43 (3): 474-484.
4. Maggio M, Guralnik JM, Longo DL, Ferrucci L, (2006) Interleukin-6 in aging and chronic disease: a magnificent pathway. J Gerontol A Biol Sci Med Sci; 61 (6): 575-584.
5. Pai JK, Pischon T, Ma J, Manson JE, Hankinson SE, et al. (2004) Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med; 351 (25): 2599-2610.
6. Cesari M, Penninx BW, Newman AB, Kritchevsky SB, Nicklas BJ, et al. (2003) Inflammatory markers and onset of cardiovascular events: results from the Health ABC study. Circulation; 108 (19): 2317-2322.
7. Ridker PM, Rifai N, Stampfer MJ, Hennekens CH, (2000) Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation; 101 (15): 1767-1772.
8. Schieffer B, Schieffer E, Hilfiker-Kleiner D, Hilfiker A, Kovanen PT, et al. (2000) Expression of angiotensin II and interleukin 6 in human coronary atherosclerotic plaques: potential implications for inflammation and plaque instability. Circulation; 101 (12): 1372-1378.
9. Haukeland JW, Damas JK, Konopski Z, Loberg EM, Haaland T, et al. (2006) Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2. J Hepatol; 44 (6): 1167-1174.
10. Soresi M, Giannitrapani L, D'Antona F, Florena AM, La Spada E, et al. (2006) Interleukin-6 and its soluble receptor in patients with liver cirrhosis and hepatocellular carcinoma. World J Gastroenterol; 12 (16): 2563-2568.
11. Wieckowska A, Papouchado BG, Li Z, Lopez R, Zein NN, et al. (2008) Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis. Am J Gastroenterol; 103 (6): 1372-1379.
12. Barrett-Connor E, Suarez L, (1982) A community study of alcohol and other factors associated with the distribution of high density lipoprotein cholesterol in older vs. younger men. Am J Epidemiol; 115 (6): 888-893.
13. Loomba R, Bettencourt R, Barrett-Connor E, (2009) Synergistic association between alcohol intake and body mass index with serum alanine and aspartate aminotransferase levels in older adults: the Rancho Bernardo Study. Aliment Pharmacol Ther; 30 (11-12): 1137-1149.
14. Laughlin GA, Barrett-Connor E, Criqui MH, Kritz-Silverstein D, (2004) The prospective association of serum insulin-like growth factor I (IGF-I) and IGF-binding protein-1 levels with all cause and cardiovascular disease mortality in older adults: the Rancho Bernardo Study. J Clin Endocrinol Metab; 89 (1): 114-120.
15. Harris TB, Ferrucci L, Tracy RP, Corti MC, Wacholder S, et al. (1999) Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med; 106 (5): 506-512.
16. Arai Y, Takayama M, Gondo Y, Inagaki H, Yamamura K, et al. (2008) Adipose endocrine function, insulin-like growth factor-1 axis, and exceptional survival beyond 100 years of age. J Gerontol A Biol Sci Med Sci; 63 (11): 1209-1218.
17. Jylha M, Paavilainen P, Lehtimaki T, Goebeler S, Karhunen PJ, et al. (2007) Interleukin-1 receptor antagonist, interleukin-6, and C-reactive protein as predictors of mortality in nonagenarians: the vitality 90+ study. J Gerontol A Biol Sci Med Sci; 62 (9): 1016-1021.
18. Baune BT, Rothermundt M, Ladwig KH, Meisinger C, Berger K, (2011) Systemic inflammation (Interleukin 6) predicts all-cause mortality in men: results from a 9-year follow-up of the MEMO Study. Age (Dordr); 33 (2): 209-217.
19. Volpato S, Guralnik JM, Ferrucci L, Balfour J, Chaves P, et al. (2001) Cardiovascular disease, interleukin-6, and risk of mortality in older women: the women's health and aging study. Circulation; 103 (7): 947-953.
20. Stork S, Feelders RA, van den Beld AW, Steyerberg EW, Savelkoul HF, et al. (2006) Prediction of mortality risk in the elderly. Am J Med; 119 (6): 519-525.
21. Preti HA, Cabanillas F, Talpaz M, Tucker SL, Seymour JF, et al. (1997) Prognostic value of serum interleukin-6 in diffuse large-cell lymphoma. Ann Intern Med; 127 (3): 186-194.
22. George DJ, Halabi S, Shepard TF, Sanford B, Vogelzang NJ, et al. (2005) The prognostic significance of plasma interleukin-6 levels in patients with metastatic hormone-refractory prostate cancer: results from cancer and leukemia group B 9480. Clin Cancer Res; 11 (5): 1815-1820.
23. Knupfer H, Preiss R, (2010) Serum interleukin-6 levels in colorectal cancer patients-a summary of published results. Int J Colorectal Dis; 25 (2): 135-140.
24. Trompet S, de Craen AJ, Mooijaart S, Stott DJ, Ford I, et al. (2009) High Innate Production Capacity of Proinflammatory Cytokines Increases Risk for Death from Cancer: Results of the PROSPER Study. Clin Cancer Res; 15 (24): 7744-7748.
25. Blindenbacher A, Wang X, Langer I, Savino R, Terracciano L, et al. (2003) Interleukin 6 is important for survival after partial hepatectomy in mice. Hepatology; 38 (3): 674-682.
26. Tiberio GA, Tiberio L, Benetti A, Cervi E, Montani N, et al. (2008) IL-6 Promotes compensatory liver regeneration in cirrhotic rat after partial hepatectomy. Cytokine; 42 (3): 372-378.
27. Sun Z, Klein AS, Radaeva S, Hong F, El-Assal O, et al. (2003) In vitro interleukin-6 treatment prevents mortality associated with fatty liver transplants in rats. Gastroenterology; 125 (1): 202-215.
28. Kugelmas M, Hill DB, Vivian B, Marsano L, McClain CJ, (2003) Cytokines and NASH: a pilot study of the effects of lifestyle modification and vitamin E. Hepatology; 38 (2): 413-419.
29. Hill DB, Marsano L, Cohen D, Allen J, Shedlofsky S, et al. (1992) Increased plasma interleukin-6 concentrations in alcoholic hepatitis. J Lab Clin Med; 119 (5): 547-552.
30. Park EJ, Lee JH, Yu GY, He G, Ali SR, et al. (2010) Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression. Cell; 140 (2): 197-208.
31. Naugler WE, Sakurai T, Kim S, Maeda S, Kim K, et al. (2007) Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science; 317 (5834): 121-124.
32. Bromberg J, Wang TC, (2009) Inflammation and cancer: IL-6 and STAT3 complete the link. Cancer Cell; 15 (2): 79-80.
33. He G, Karin M, (2011) NF-kappaB and STAT3- key players in liver inflammation and cancer. Cell Res; 21 (1): 159-168.
34. Ruhl CE, Everhart JE, (2009) Elevated serum alanine aminotransferase and gamma-glutamyltransferase and mortality in the United States population. Gastroenterology; 136 (2): 477-85.e11.
35. Everhart JE, Ruhl CE, (2009) Burden of digestive diseases in the United States Part III: Liver, biliary tract, and pancreas. Gastroenterology; 136 (4): 1134-1144.0.
36. Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, et al. (2006) The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med; 144 (10): 705-714.